MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 11-13-2023
Eloxx Pharmaceuticals ROA Ratio 2011-2025 | ELOX
Annual ROA Ratio Eloxx Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -170.74 | -147.83 | -130.59 | -86.3 | -93.03 | -99.16 | -89.62 | -92.41 | -27.67 | -86.26 | -72.84 | -84.55 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -27.67 | -170.74 | -98.42 |
Quarterly ROA Ratio Eloxx Pharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -246.35 | -214.83 | -174.63 | -86.81 | -104.65 | -94.57 | -121.83 | -120.03 | -145.02 | -152.16 | -122.46 | -107.45 | -129.29 | -126.14 | -120.87 | -66.57 | -88.58 | -88.74 | -90.66 | -65.38 | -108.15 | -102.44 | -91.66 | -79.83 | -62.31 | -59.32 | -73.36 | -78.36 | -77.76 | -65.37 | -55.42 | -46.22 | -79.5 | -96.99 | -109.5 | -124.13 | -80.8 | -93.06 | -83.64 | -93.23 | -101.89 | -104.51 | -99.95 | -104.8 | -103.83 | -83.08 | -82.59 | -64.69 | -12.56 | -17.77 | -12.09 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -12.09 | -246.35 | -96.39 |
ROA Ratio of other stocks in the Biotechnology industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ARCA biopharma
ABIO
|
-21.14 | - | 1052.0 % | $ 415 M |  USA |
 |
AbbVie
ABBV
|
-0.02 | $ 223.98 | -0.53 % | $ 396 B | USA |
 |
Alpine Immune Sciences
ALPN
|
-20.15 | - | - | $ 2.17 B | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
-50.45 | $ 4.67 | 1.74 % | $ 775 M |  Canada |
 |
Aclaris Therapeutics
ACRS
|
-59.94 | $ 3.36 | 2.75 % | $ 260 M | USA |
 |
AlloVir
ALVR
|
-49.57 | - | 4.14 % | $ 49.1 M | USA |
 |
Acasti Pharma
ACST
|
-13.29 | - | 4.01 % | $ 150 M | Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
-40.29 | - | -15.15 % | $ 60.3 M |  Britain |
 |
Ampio Pharmaceuticals
AMPE
|
-150.49 | - | -11.43 % | $ 502 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-34.19 | - | - | $ 1.01 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.33 | - | - | $ 40.3 B | USA |
 |
Albireo Pharma
ALBO
|
-11.27 | - | -0.23 % | $ 916 M | USA |
 |
Ascendis Pharma A/S
ASND
|
-35.36 | $ 210.16 | 4.43 % | $ 5 B |  Danmark |
 |
Ayala Pharmaceuticals
AYLA
|
-489.29 | - | - | $ 7.46 M |  Israel |
 |
Aptorum Group Limited
APM
|
-26.46 | $ 1.33 | -1.48 % | $ 7.25 M |  China |
 |
Alterity Therapeutics Limited
ATHE
|
-31.06 | $ 3.42 | 2.09 % | $ 8.23 B |  Australia |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-53.39 | - | -1.52 % | $ 24.7 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
10.11 | $ 25.9 | 0.74 % | $ 1.25 B | USA |
 |
AstraZeneca PLC
AZN
|
0.11 | $ 90.29 | - | $ 96.9 B | Britain |
 |
Anika Therapeutics
ANIK
|
-30.55 | $ 9.49 | - | $ 139 M | USA |
 |
Brickell Biotech
BBI
|
-49.15 | - | -5.38 % | $ 6.06 M | USA |
 |
BeiGene, Ltd.
BGNE
|
-10.89 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Bellicum Pharmaceuticals
BLCM
|
-104.83 | - | -9.72 % | $ 5.89 M | USA |
 |
Berkeley Lights
BLI
|
-43.36 | - | -7.31 % | $ 87 M | USA |
 |
Aytu BioScience
AYTU
|
-10.92 | $ 2.28 | - | $ 14.3 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
-78.56 | - | -6.81 % | $ 3.04 B | USA |
 |
Biogen
BIIB
|
5.82 | $ 172.5 | - | $ 25.1 B | USA |
 |
Baudax Bio
BXRX
|
-586.07 | - | 0.59 % | $ 63 K | USA |
 |
Avenue Therapeutics
ATXI
|
-437.72 | - | -52.27 % | $ 4.45 M | USA |
 |
Benitec Biopharma
BNTC
|
-8.84 | $ 12.96 | 1.17 % | $ 533 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
4.82 | - | - | - |  Russia |
 |
ChromaDex Corporation
CDXC
|
12.52 | - | -0.88 % | $ 598 M | USA |
 |
Axon Enterprise
AXON
|
8.43 | $ 581.03 | 2.22 % | $ 44 B | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-86.4 | $ 0.29 | -0.31 % | $ 631 M | Israel |
 |
Checkpoint Therapeutics
CKPT
|
-752.78 | - | - | $ 169 M | USA |
 |
Caladrius Biosciences
CLBS
|
-57.1 | - | -16.75 % | $ 25.8 M | USA |
 |
Catalyst Biosciences
CBIO
|
-73.35 | $ 15.31 | - | $ 1.01 B | USA |
 |
Clovis Oncology
CLVS
|
-55.94 | - | -7.23 % | $ 13 M | USA |
 |
Cerus Corporation
CERS
|
-10.41 | $ 2.15 | 13.76 % | $ 397 M | USA |
 |
BioVie
BIVI
|
-81.36 | $ 1.51 | -4.43 % | $ 2.23 M | USA |
 |
Cortexyme
CRTX
|
-18.69 | - | -1.05 % | $ 67.1 M | USA |
 |
Celldex Therapeutics
CLDX
|
-19.92 | $ 27.94 | - | $ 1.8 M | USA |
 |
Cellectar Biosciences
CLRB
|
-354.19 | $ 3.78 | -5.97 % | $ 46.2 M | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
-41.16 | - | - | $ 2.18 B | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-78.59 | $ 11.44 | 7.92 % | $ 740 M | USA |
 |
BioNTech SE
BNTX
|
65.02 | $ 96.0 | - | $ 27.2 B |  Germany |
 |
Acer Therapeutics
ACER
|
-225.71 | - | 2.71 % | $ 14 M | USA |
 |
Enochian Biosciences
ENOB
|
-2162.69 | - | - | $ 40.5 M | USA |
 |
Epizyme
EPZM
|
-86.89 | - | - | $ 249 M | USA |